Literature DB >> 641845

A radioimmunoassay for the determination of combined amitriptyline and nortriptyline concentrations in microliter samples of plasma.

J D Robinson, D Risby, G Riley, G W Aherne.   

Abstract

A sensitive radioimmunoassay for amitriptyline and nortriptyline in blood has been developed. The antibodies used in the radioimmunoassay were raised in a sheep against a conjugate of nortriptyline and bovine serum albumin. Using tritiated amitriptyline as the label, the assay is capable of detecting concentrations as low as 2.0 ng/ml in a 50 microliter sample of plasma. Cross-reactivity studies have demonstrated the specificity of the radioimmunoassay for both amitriptyline and nortriptyline, and comparison with gas-liquid chromatography assay has indicated the applicability of the assay to a routine situation. The radioimmunoassay has been used to study the plasma drug levels after single oral administration of amitriptyline to four volunteers. A wide variation in maximum drug concentrations, ranging from 18 to 62 ng/ml, was seen, with the time taken to reach the maxima ranging between 1.5 and 3 hours. A second concentration peak was seen in three of the volunteers, at 4 to 5 hours after ingestion of the drug.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 641845

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  2 in total

1.  The relationships between clinical response, psychophysiological variables and plasma levels of amitriptyline and diazepam in neurotic outpatients.

Authors:  E C Johnstone; R C Bourne; T J Crow; C D Frith; S Gamble; R Lofthouse; F Owen; D G Owens; J Robinson; M Stevens
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

2.  A comparison of the pharmacodynamic profiles of nomifensine and amitriptyline in normal subjects.

Authors:  M Y Chan; R Ehsanullah; J Wadsworth; J McEwen
Journal:  Br J Clin Pharmacol       Date:  1980-03       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.